New antibiotic tested against superbugs in chinese hospitals
NCT ID NCT07268560
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
Some bacterial infections have become resistant to common antibiotics, making them very hard to treat. This study looks at a new drug combination, aztreonam-avibactam, in about 100 hospitalized adults in China with these resistant infections. Researchers will track how well patients respond to treatment and gather information to help doctors use this drug more effectively.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Aztreonam-Avibactam (antibiotic combination)
What this could lead to
If successful, this study could provide real-world evidence that aztreonam-avibactam is an effective treatment for drug-resistant infections, helping doctors choose the right therapy.
What could go wrong
This is an observational study, not a controlled trial, so results may be less definitive. The drug is new, and long-term safety or effectiveness in diverse patients is still unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTILATOR-ASSOCIATED PNEUMONIA (VAP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sir Run Run Shaw Hospital
NOT_YET_RECRUITINGHangzhou, Zhejiang, 310016, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••